Literature DB >> 12971334

FDA approves Gleevec for pediatric leukemia.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12971334

Source DB:  PubMed          Journal:  FDA Consum        ISSN： 0362-1332


× No keyword cloud information.
  2 in total

Review 1.  Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients.

Authors:  Thomas D Ryan; Rajaram Nagarajan; Justin Godown
Journal:  Curr Treat Options Oncol       Date:  2019-05-25

2.  Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias.

Authors:  Stephanie M Smith; Himalee S Sabnis; Rebecca Williamson Lewis; Karen E Effinger; John Bergsagel; Briana Patterson; Ann Mertens; Kathleen M Sakamoto; Lidia Schapira; Sharon M Castellino
Journal:  BMC Cancer       Date:  2021-04-29       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.